XML 42 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current    
Cash and cash equivalents (notes 8 and 17) $ 309,857 $ 108,977
Short-term Investments 210,000 0
Restricted cash – current (notes 10, 15 and 17) 3,714 2,227
Accounts receivable 140,837 59,951
Accrued revenue 82,923 44,503
Bunker and lube oil inventory 60,832 49,033
Prepaid expenses 15,442 14,020
Current portion of net investment in sales-type lease, net (note 2) 0 12,009
Assets held for sale (note 18) 0 43,543
Current assets - discontinued operations (note 23) 0 4,804,439
Total current assets 823,605 5,138,702
Non-current    
Restricted cash – non-current 3,135 3,135
Vessels and equipment (note 8)    
At cost, less accumulated depreciation of $171,800 (2021 – $271,900) 429,987 925,249
Vessels related to finance leases, at cost, less accumulated amortization of $290,000 (2021 – $112,900) (note 10) 823,381 411,749
Operating lease right-of-use assets (notes 1 and 9) 42,894 14,257
Total vessels and equipment 1,296,262 1,351,255
Investment in and loan to equity-accounted investment (note 22) 16,198 12,954
Goodwill, intangibles and other non-current assets (notes 5 and 15) 25,646 25,936
Total assets 2,164,846 6,531,982
Current    
Accounts payable 47,371 41,081
Accrued liabilities and other (notes 6) 86,971 103,063
Short-term debt (note 7) 0 25,000
Current portion of long-term debt (note 8) 21,184 255,306
Current obligations related to finance leases (note 10) 60,161 27,032
Current portion of operating lease liabilities (notes 1 and 9) 16,585 9,389
Current liabilities - discontinued operations (note 23) 0 2,877,629
Total current liabilities 232,272 3,338,500
Long-term debt (note 8) 0 416,174
Long-term obligations related to finance leases (note 10) 472,599 267,449
Long-term operating lease liabilities (notes 1 and 9) 26,858 4,868
Other long-term liabilities (notes 6) 63,511 72,508
Total liabilities 795,240 4,099,499
Equity    
Common stock and additional paid-in capital ($0.001 par value; 725,000,000 shares authorized; 98,318,395 shares outstanding and 102,077,387 shares issued (2021 – 101,571,141 shares outstanding and issued)) (note 12) 1,022,040 1,053,802
Accumulated deficit (396,605) (513,242)
Non-controlling interest 746,143 1,917,433
Accumulated other comprehensive loss (note 1) (1,972) (25,510)
Total equity 1,369,606 2,432,483
Total liabilities and equity 2,164,846 6,531,982
Supplemental Balance Sheet Elements [Abstract]    
Accumulated depreciation 171,800 271,900
Sale Leaseback Transaction, Accumulated Depreciation $ 290,000 $ 112,900
Common stock, share authorized (in shares) 725,000,000 725,000,000
Common Stock, Shares, Outstanding 98,318,395 101,571,141
Common stock, share issued (in shares) 102,077,387 101,571,141